Neuronal Genome Mosaicism: A Molecular Component Of Cognition?
Funder
National Health and Medical Research Council
Funding Amount
$687,975.00
Summary
The brain is a complex and dynamic organ tasked with interpreting and responding to the world around us. My recent work has shown that mobile genetic elements, or 'jumping genes', cause changes in the DNA of brain cells, potentially altering how they work. During the course of this fellowship, I will examine how and when during life these DNA changes occur, whether they play a role in memory formation, and whether they contribute to neurodevelopmental and mental health conditions.
The research focuses on how gene function is networked and the ways that cells talk to each other to coordinate their activity in the formation of organs and body parts. Knowledge gleaned from these investigations will enhance our understanding of the genetic control underpinning normal development and the errors that lead to birth defects. The elucidation of the process that turns naive cells into the right cell type is essential for the use of stem cells for cell therapy and tissue repair.
Professor Paul Baird specialises in identifying and understanding how genetic changes associated with common eye diseases including age-related macular degeneration and keratoconus lead to vision loss and blindness. This fellowship will allow him to uncover novel genetic contributors in these diseases using next-generation molecular techniques. He will assess functionality of these variants, allowing him to translate these findings back to the clinic allowing personalised treatment options.
Identification Of Novel Treatment Strategies For Human Cancers Through Integrative Phosphoproteomics And Kinomics.
Funder
National Health and Medical Research Council
Funding Amount
$763,409.00
Summary
This proposal aims to use new cutting-edge techniques to characterize, at a global level, changes in growth regulatory signals in cancer cells. This will identify proteins critical for cancer growth that represent potential targets for therapy. In addition it will highlight ways to select the most effective treatments for individual patients. The ultimate outcome of this work will be improved treatment strategies for cancer patients, and hence reduced morbidity and mortality.
Cancer is linked to mutations in a large variety of genes but how these changes impact on cell behaviour is often unknown. We are using functional genomics in zebrafish to identify genes that are essential for rapid rates of proliferation by intestinal epithelial cells. Seven genes have been cloned so far and our next task is to analyse, using mouse models and human cancer transcriptome analysis, whether any are indispensable for cancer growth and thereby present suitable targets for therapy.